Interreg Baltic Sea Region Programme: ProVaHealth, BiC and BaltCityPrevention selected for the 2nd step.
The three concept notes Product Validation in Health (ProVaHealth), Biomarker Commercialization (BiC) and Baltic Cities tackle lifestyle related diseases (BaltCityPrevention) prepared for the Interreg Baltic Sea Region programme were selected for the 2nd step.
The Monitoring Committee reviewed 212 concept notes submitted by the project applicants in the first step and selected 75 of them to participate in the second step, which will close on 17 January 2017.
Read more here.
16 November 2017
India Pharma 2018 (Bengaluru)